FDA allows Philip Morris-owned Zyn marketed as less harmful cigarettes

Key Points:

• The FDA has authorized Philip Morris-owned Zyn nicotine pouches to be marketed with claims that switching from cigarettes to Zyn reduces the risk of several major diseases, marking a significant regulatory victory for the tobacco company.
• Zyn pouches contain nicotine but no tobacco and are positioned as a cleaner alternative to cigarettes and chewing tobacco, gaining popularity among conservatives, tech workers, and others.
• Despite the approval, the FDA emphasized that Zyn is not safe, warning that no tobacco product is safe and that youth and non-tobacco users should avoid these products.
• The decision aligns with the Trump administration's more industry-friendly stance on nicotine products, reversing earlier restrictions and allowing some flavored e-cigarettes and nicotine pouches to remain on the market during FDA review.
• Zyn has become culturally significant within conservative circles, with figures like Tucker Carlson promoting nicotine pouches, and the product's approval reflects growing investment in smoke-free alternatives amid declining cigarette sales.